Sign in

CIK 0000812796 · Non-accelerated filer<br>Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
411505029
Phone
609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
  1. EFFECT Other Notice of Effectiveness
  2. EFFECT Other Notice of Effectiveness
  3. EFFECT Other Notice of Effectiveness
  4. EFFECT Other Notice of Effectiveness
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. POS AM Other Post-effective Amendment for Registration Statement
  8. UPLOAD Other SEC-generated Letter
  9. S-1 Offering Registration Statement
  10. POS AM Other Post-effective Amendment for Registration Statement
  11. POS AM Other Post-effective Amendment for Registration Statement
  12. POS AM Other Post-effective Amendment for Registration Statement
  13. POS AM Other Post-effective Amendment for Registration Statement
  14. 10-K Report Annual Report
  15. 8-K Event Agreement ended
  16. 8-K Event Regulation FD disclosure
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 27 of 72 · 1,429 filings